Yanling Wang
- Pharmacology top 1%
- Fungal Biology and Applications 2
- Pharmacology top 1%
- Fungal Biology and Applications 2
- Ophthalmology top 5%
- Retinal Diseases and Treatments 9
- Glaucoma and retinal disorders 7
- Retinal and Optic Conditions 2
- Molecular Medicine top 10%
-
- Retinal Imaging and Analysis 3
-
- Neonatal Health and Biochemistry 2
-
- Cerebrovascular and Carotid Artery Diseases 2
-
- Retinal Development and Disorders 2
- Co-authors
- Cong LiShukui WangShuyi SiParveen AbidiJian‐Dong JiangWeijia KongYue WangZhuorong Li
- Journals
- Circulation (1 paper)Nature Medicine (1 paper)Applied and Environmental Microbiology (1 paper)
- Partner nations
- ChinaUnited StatesMyanmar
In The Last Decade
Yanling Wang
28 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pharmacology 809
- Pharmacology 353
- Endocrinology, Diabetes and Metabolism 199
- Ophthalmology 98
- Molecular Medicine 47
Countries citing papers authored by Yanling Wang
This map shows the geographic impact of Yanling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Wang more than expected).
Fields of papers citing papers by Yanling Wang
This network shows the impact of papers produced by Yanling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Wang. The network helps show where Yanling Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 31 | |
| 12 | 2020 | 8 | |
| 13 | 2018 | 4 | |
| 14 | 2017 | 65 | |
| 15 | 2017 | 28 | |
| 16 | 2013 | 1 | |
| 17 | [Genetic transformation of the fungus Gliocladium sp. mediated by Agrobacterium tumefaciens]. | 2013 | 2 |
| 18 | 2012 | 1 | |
| 19 | 2010 | 7 | |
| 20 | Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statinsbreakdown → | 2004 | 1171 |
About Yanling Wang
Yanling Wang is a scholar working on Ophthalmology, Rehabilitation and Occupational Therapy, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (9 papers), Glaucoma and retinal disorders (7 papers), Retinal Imaging and Analysis (3 papers), Neonatal Health and Biochemistry (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Retinal and Optic Conditions (2 papers), Retinal Development and Disorders (2 papers) and Fungal Biology and Applications (2 papers). The work is most often cited by research in Pharmacology (809 citations), Pharmacology (353 citations) and Endocrinology, Diabetes and Metabolism (199 citations). Yanling Wang has collaborated with scholars based in China, United States and Myanmar. Frequent co-authors include Cong Li, Shukui Wang, Shuyi Si, Parveen Abidi, Jian‐Dong Jiang, Weijia Kong, Yue Wang, Zhuorong Li, Jing Wei and Meihong Lin. Their work appears in journals such as Circulation, Nature Medicine and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.